Efficacy of Bacopa Monnieri in Enhancing Cognitive Outcomes and Its Therapeutic Potential for ADHD: A Metasynthesis

Abstract

During the COVID-19 pandemic, there was a significant alteration in students' conventional learning ecosystems, which consequently led to concerns regarding potential reductions in cognitive functions and academic prowess. This manuscript offers a comprehensive metasynthesis of scientific studies examining the efficacy of Bacopa Monnieri in enhancing cognitive learning outcomes for students in the aftermath of the pandemic. Systematic analysis indicates that the use of Bacopa Monnieri supplements is correlated with a reduction in hyperactivity, augmentation of memory retention, amplified concentration, and an absence of detrimental side effects. Our review encompasses research involving healthy senior individuals, school-going children, individuals diagnosed with ADHD, and medical students. The evidence consistently demonstrates benefits, including enhanced cognitive processing, heightened attention, diminished hyperactivity, and reductions in symptoms of anxiety and depression. Thus, Bacopa Monnieri is positioned as a potent natural solution for augmenting students' cognitive functions and academic achievements, with potential benefits extending beyond the backdrop of the pandemic.